コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 abling ctDNA detection in 96% of patients at baseline.
2 among HIV-positive MSM without dysplasia at baseline.
3 is defined using changes in creatinine from baseline.
4 f T2D, cardiovascular disease, and cancer at baseline.
5 ated pituitary dome depression compared with baseline.
6 d to PCIT-ED vs. 55 assigned to waitlist) at baseline.
7 erences among patients who had had angina at baseline.
8 d women aged 64.44 (SD 8.49) y on average at baseline.
9 o remain more similar to their pre-treatment baseline.
10 986-2016) who were free of CVD and cancer at baseline.
11 ed depressive symptoms and no CVD history at baseline.
12 ne, or increase in glaucoma medications from baseline.
13 s increase their activity level, compared to baseline.
14 rrow Transplant (FACT-BMT) score relative to baseline.
17 gression among 15,612 adults aged 40-78 y at baseline (1993-1997) and followed up over 1998-2000 (mea
19 most prevalent in both HIV-negative (38% at baseline, 30% at the follow-up visit) and HIV-positive (
20 A total of 6632 patients were included; at baseline, 3352 (50.5%) did not have diuretics, 2195 (33.
25 sample included 252 745 women (median age at baseline, 57 years) with 38% self-reporting use of powde
27 .4 (22.7) minutes in the intervention group (baseline-adjusted difference [95% confidence interval] -
28 oplasia at each subsequent examination after baseline, adjusting for multiple colonoscopies within in
30 ork Heart Association class were assessed at baseline (after randomization) and at each follow-up vis
33 oidism, adjusting for depressive symptoms at baseline, age, sex, education, and income (PROSPERO CRD4
35 ic mean FIA[-SD, +SD](%) from doses given at baseline, alternate days, and every third day did not di
36 paired group, younger age (P = 0.02), higher baseline amyloid PET (P = 0.05), APOE epsilon4 (P = 0.05
39 enic progressive aphasia) that had undergone baseline and 1-year follow-up MRI and flortaucipir PET.
45 t 26 weeks in the CGM group and 8.9% at both baseline and 26 weeks in the BGM group (adjusted between
46 ithine, polyamines, and acetyl polyamines at baseline and 26 wk of intervention were measured by an u
51 2) 18 patients with ajmaline-induced BrS (at baseline and after ajmaline), in whom epicardial potenti
56 study design, PET/CT scans were performed at baseline and before starting maintenance (premaintenance
59 rticipants with mild cognitive impairment at baseline and either no neuritic plaques (i.e. primary ag
67 to PCIT-ED (n = 60) or waitlist (n = 58) at baseline and late positive potential (LPP) data from 99
69 5.1-5.9) years, 8828 participants provided a baseline and one or more follow-up MoCA or DSST scores,
75 pared for all patients before the procedure (baseline) and on postoperative day 90: MRD1, Ocular-Surf
76 t (n = 23) ADHD completed the bandit task at baseline, and after methylphenidate or placebo in counte
79 ed novelty-induced locomotor activity, lower baseline anxiety, and motivational deficits in operant c
86 g, this combined dataset represents a global baseline available for interrogation by future microbial
90 In total, 1.5T MRI images were acquired at baseline before commencing clozapine and again after 6 m
91 sleep such that students with shorter TIB at baseline before the first COVID-19 cases emerged locally
94 sites which had presented with recession at baseline but were not treated showed a significantly mor
95 is undetectable in the adult mouse heart at baseline, but mRNA and protein are induced after ischemi
96 60 SZ individuals demonstrated that COPD at baseline, but not former smoking or AAT concentrations,
97 t health centers met the Healthy People 2020 baseline, but opportunities for improvement remain and t
100 D4 deletion in cardiomyocytes did not affect baseline cardiac size or function in young adult mice.
102 independently lower among participants with baseline CD4 count >=500 cells/uL (3.3%) compared to tho
103 n the non-randomised cohort died; the median baseline CD4 count for participants who died was 11 cell
104 Th1 phenotype were the predominant subset at baseline, cells with phenotypic and transcriptional char
105 luspatercept and 76 to receive placebo; the baseline characteristics of the patients were balanced.
111 ml/min per 1.73 m(2) and >=25% decline from baseline, CKD-related hospitalization or death, or ESKD.
113 pensity-score weighting, the distribution of baseline clinical and radiological variables was similar
114 n-school clustering, minimisation variables, baseline cluster-level score of the outcome, and sociode
115 ductions were also greater in subgroups with baseline coagulation biomarker levels at or above median
116 icant association with cognitive function at baseline, cognitive decline or with conversion rates to
120 mption of 1 + servings per week of yogurt at baseline, compared to no yogurt consumption, was associa
122 es from nonresponders (P = .04) and distinct baseline composition (P = .04), but no specific marker t
123 deforestation affects climate is the lack of baseline conditions (i.e., prior to human disturbance) o
124 s were then retested in the task, under both baseline conditions and following administration of estr
125 hose of static culture conditions under both baseline conditions and with exposure to ST enterotoxin
128 l Rit2 knockdown in DAergic neurons impacted baseline DAT surface:intracellular distribution in DAerg
129 iversity and inclusion within SER to provide baseline data for future evaluations of Society initiati
131 7% vs 23.1% p = 0.04) despite overall larger baseline defect size (32.7 +/- 19.5 mm(2) vs 21.5 +/- 10
133 patients registered before 2018), including baseline demographics, donor, biochemical and clinical d
138 se with/without anxiety after accounting for baseline dissimilarities in symptom scores (all p(intera
139 P = 0.014), and mean FIA [+/-SD](%) from the baseline dose [23.3 (10.9)] was greater than that from t
141 there was no significant association between baseline eGFR <60 ml/min per 1.73 m(2) and risk for deme
142 f-reported race (Black, White, or other) and baseline eGFR with AKI incidence among patients who unde
143 /90 mm Hg, higher glycated hemoglobin, lower baseline eGFR, and higher baseline urine albumin/creatin
144 e, sex, diabetes, treatment with an ARNI and baseline eGFR, but suggested treatment-by-subgroup inter
148 ertugliflozin was observed in 3 populations: baseline estimated glomerular filtration rate <60 mL.min
150 eyes with 4-year follow-up, VA changes from baseline (ETDRS letters) were least squares means of +1.
151 n magnetic resonance images were obtained at baseline, every 3 days after exposure for 2 weeks, and t
152 This effect was stronger in muscles with baseline FF below the mean +/- standard deviation of una
153 We found that deep layer neurons show higher baseline firing rates (FRs) in GC with deep-layer inhibi
154 o image onset, showing large deviations from baseline firing shortly after image onset but relaxing b
155 ctional magnetic resonance imaging, but only baseline focal hippocampal atrophy predicted progression
157 he first empirical evidence and an important baseline for ingestion of microplastics and other anthro
158 ina frequency was increased by 13.7 units at baseline ([Formula: see text], 13.7 [95% CI, 6.3-21.7];
159 not trophic status or body size, is the best baseline from which to predict organismal body nutrient
160 factors in addition to GI and genitourinary baseline function, with higher scores representing bette
164 Even eyes that were severely ischemic at baseline had no significant changes in RNP area 1 year a
165 dividuals with only 1 or 2 small adenomas at baseline have a low risk of advanced neoplasia over 10 y
166 ts without persistent opioid use returned to baseline health care spending within 6 months, regardles
167 easuring HVPG response only if the patient's baseline HVPG is over 16 mm Hg improves detection of hig
172 e aortic stenosis undergoing TAVR, even with baseline impaired eGFR, CKD stage is more likely to stay
175 s achieving a 50% or higher improvement from baseline in F-VASI (F-VASI50) at week 24, assessed in th
176 tum microbiota showed greater deviation from baseline in ICS nonresponders than in ICS responders.
177 secondary outcomes included the change from baseline in itch-related quality-of-life measures, the p
180 The difference at day 85 in the change from baseline in the CSF SOD1 concentration between the tofer
181 progressive MS at 30 years were presence of baseline infratentorial lesions and deep white matter le
182 or guideline-concordant duration) during the baseline, intervention, and postintervention periods, re
183 infected woodchucks; the identification of a baseline intrahepatic transcriptional signature associat
184 ariable logistic regression analysis, higher baseline IOP predicted higher odds of POD1 IOP spike >40
186 Antibiotic prescribing was compared in the baseline (January-June 2016), intervention (January-June
187 erage sample size 136,000), we show that the Baseline LD model is more realistic than other existing
190 esponse to facial affect stimuli returned to baseline levels while positive affect remained elevated,
191 egression model adjusting for the effects of baseline MD and age, cataract extraction, interactions,
194 recruited from February 2004 to May 2006 for baseline measurements, and follow-up was performed 48 mo
195 art rate variability (HRV), and the averaged baseline measures of HRV to heart rate recovery (HRR) fo
200 e significantly narrower than of a two-stage baseline method that first estimates the variance compon
201 ability to infection was not associated with baseline microbiome but was reproduced in mice by preinf
207 rans 75 years and older and free of ASCVD at baseline, new statin use was significantly associated wi
208 with a history of lung cancer (P < .001), a baseline nodule volume less than 500 mm(3) (P = .03), an
210 achieved SVR, which was not associated with baseline OAT status (P = .33), on-treatment drug use (P
212 (IOP) >18 mm Hg or not reduced by 30% below baseline on 2 consecutive follow-up visits after 3 month
213 isits: IOP >21 mmHg, IOP reduction <20% from baseline, or increase in glaucoma medications from basel
215 to TT, PT, and PCV serotypes increased from baseline (P < .001 for all antigens) and remained elevat
223 ET) scans with two different radiotracers at baseline prior to brexpiprazole administration, and agai
225 ifferences in body size, blood pressure, and baseline pulmonary capillary wedge pressure between grou
226 ith the level of cognitive ability at age-70 baseline (range of standardized beta-values = -0.178 to
228 s transitioned abruptly between aberrant and baseline reach kinematics in a dopamine-dependent manner
230 ock size six; 1:1:1) was done, stratified by baseline Richmond Agitation Sedation Scale (RASS) scores
232 y design: phase I, 2-minute resting state at baseline (room air); phase II, 6-minute maternal hyperox
236 hs, and the secondary endpoints (efficacy by baseline serostatus, serotype, hospitalised dengue, and
237 t committee made 1 strong recommendation for baseline serum calcium testing, 13 conditional recommend
239 rds models estimated the association between baseline serum retinol quintile and overall and site-spe
240 t cell (MC) activation symptoms and elevated baseline serum tryptase level (MCAS-T) may not necessari
242 rderline worse vision and thicker maculae at baseline, showed larger CST reductions after 12 months o
243 ntional monocytes and pMos revealed distinct baseline signaling profiles and far greater heterogeneit
244 roup, sensitivity of the highest-performing (baseline) SSD was 81% (95% confidence interval [CI]: 80%
247 PRS and depression when under stress than at baseline, suggesting that MDD-PRS adds unique predictive
248 ho self-reported poor adherence) completed a baseline survey that assessed the following: (1) demogra
250 hicker maculae (mean difference, +26 mum) at baseline than those receiving ranibizumab, which were no
252 patients with negative [TIMP-2]*[IGFBP7] at baseline, those who became positive (>0.3 units) after r
255 nnaire overall summary score [KCCQ-OS]) from baseline to 1 month and the composite rate of death or H
256 levels decreased from 26.3 +/- 10.7 ng/mL at baseline to 20.8 +/- 8.1 and 20.8 +/- 8.5 ng/mL at 24 an
259 the short form 36 sum or domain scores from baseline to 5 years, except for the short form 36 role e
260 Medication adherence improved from 59.9% at baseline to 81.3% (P < 0.0001) after completing the SEE
262 together, our results provide a quantitative baseline to constrain model-based hypotheses of plant re
264 ice was active, walking speed increased from baseline to immediately after the intervention on flat a
268 Mean change in square root area of MA from baseline to month 24 was +0.36 mm (95% confidence interv
269 in a statistically significant fashion from baseline to month 3 in all 3 groups by 1.4% to 2.1% (P <
270 r to placebo (average difference change from baseline to week 3 through end of treatment [EOT] in MAD
271 moters serve a critical role in establishing baseline transcriptional capacity through the recruitmen
272 The flow-gradient pattern was determined at baseline transthoracic echocardiography and classified a
275 In the norm-albuminuria cohort (n = 75) baseline UPPod:CR was associated with development of alb
276 1.7 ml/min/1.73m(2)) and norm-albuminuria at baseline, UPPod:CR was associated with eGFR loss rate (P
278 0.004] for >=7 injections, respectively) and baseline VA of 20 logMAR letters or fewer (adjusted odds
281 f clinical events and their correlation with baseline virological and biochemical parameters as well
282 of exudation or proliferation with return to baseline vision (n = 2), stable mild exudation (n = 1),
284 and postintervention periods, respectively (baseline vs intervention and postintervention, P = .001
285 ion to within 2 lines of pre-endophthalmitis baseline was achieved in 53% of patients at 3 months of
286 , < 0.0001-0.03); improvement at month 18 vs baseline was higher in Cit-B12 than placebo (33% vs 15%,
287 hange in aBSI after treatment, compared with baseline, was significantly associated with OS (P < 0.00
290 reductions in central retinal thickness from baseline were 126.1, 127.1, and 126.9 mum, respectively.
292 of age, and participants who took statins at baseline were compared with those who did not using Cox
293 and not on ART with detectable viral load at baseline were randomly assigned; 666 (51%) were men.
294 status of 0-2, and had measurable disease at baseline were recruited from 35 academic and community h
295 unequivocal evidence of liver metastases at baseline whole-body MRI, two participants were excluded
296 atched control subjects to be symptomatic at baseline with a greater symptom severity score, but this
297 h patisiran were sustained from parent study baseline with treatment in the global OLE (APOLLO-patisi
300 lation consists of 250 TAVR patients in whom baseline Zva and follow-up QOL was prospectively assesse